Sales and Marketing

Showing 15 posts of 11527 posts found.

1,100% generic cancer drug price increases fly below UK radar

January 30, 2017 Manufacturing and Production, Sales and Marketing Drug pricing, European Cancer congress

If you were asked what the big topic of discussion in the pharmaceutical industry was last year, there would really …

Sanofi announces new VP of External Affairs

January 30, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi

Kathleen Tregoning has been announced as Sanofi’s vice president of External Affairs and as a new member of the Executive …

Major pharma firms join Liverpool Uni in £14m pharmacovigilance project

January 30, 2017 Research and Development, Sales and Marketing AZ, AbbVie, Eli Lilly, GSK, University of Liverpool, pharmacovigilance

The UK’s University of Liverpool is to launch a £14 million pharmacovigilance project focused on using new modelling approaches to …

Astellas and Ironwood release positive Phase 3 results for constipation drug

January 30, 2017 Research and Development, Sales and Marketing Astellas, Ironwood, constipation

Astellas Pharma, a Tokyo-based pharmaceutical, and Ironwood Pharmaceuticals, based in Cambridge, Massachusetts, have announced positive results from a Phase 3 …

MSD puts best foot forward in drug pricing debate

January 30, 2017 Medical Communications, Sales and Marketing Drug pricing, MSD, Merck

MSD, known as Merck in North America, has taken a pre-emptive step in the drug pricing debate by releasing its …

Amgen drug pair become first Humira biosimilars to win EU approval

January 30, 2017 Sales and Marketing AbbVie, Amgen, Amgevita, Humira, Solymbic, rheumatoid arthritis

Good news for Amgen as its two biosimilar versions of AbbVie’s blockbuster rheumatoid arthritis (RA) drug Humira (adalimumab) have been …

Novo Nordisk launches £115 million investment in UK despite Brexit

January 30, 2017 Research and Development, Sales and Marketing Novo Nordisk, University of Oxford, brexit

Novo Nordisk has given the UK a boost by confirming that it plans to go ahead with a £115 million …

Juno Therapeutics bring in new executive vice president

January 27, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Genentech, Roche, juno therapeutics

Juno Therapeutics has hired Corsee D. Sanders as its executive vice president and head of development operations. She will step …

Celgene’s Revlimid scores first-of-its-kind myeloma indication in EU

January 27, 2017 Sales and Marketing Celgene, Revlimid, multiple myeloma

Celgene’s Revlimid (lenalidomide) has become the first licensed monotherapy treatment for newly diagnosed multiple myeloma in patients who have undergone …

Google’s life sciences business gains $800 million funding in pivot to Asia

January 27, 2017 Medical Communications, Sales and Marketing China, Temasek, Verily, google

Verily, a life sciences company owned by Alphabet, Google’s umbrella company, has announced that it has received $800 million in …

Top Ten most popular articles on Pharmafile.com this week

January 27, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biggest news, biggest stories, top 10, top 10 stories, top stories, top ten

We’re nearing the end of the first month of the year and acqusitions have begun to introduce themselves with bang, …

Innovative routes to market: Rethinking the life sciences distribution model

January 27, 2017 Manufacturing and Production, Medical Communications, Sales and Marketing Deloitte, distribution

Originally published in the latest issue of Pharmafile, Deloitte’s life sciences director Lee Feander discusses the often-undervalued importance of distribution …

New CFO for Diurnal

January 26, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Richard Bungay has been named as the new chief financial officer (CFO) of Diurnal; he has succeeded former CFO Ian …

NICE approves Imbruvica for second-line leukaemia treatment

January 26, 2017 Medical Communications, Sales and Marketing AbbVie, CLL, Janssen, ibrutinib, imbruvica

NICE has issued its Technology Appraisal Guidance (TAG) that has recommend Imbruvica (ibrutinib) for the treatment of chronic lymphocytic leukaemia …
The Gateway to Local Adoption Series

Latest content